A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their affiliates, but is using a new line of attack ...

Merck Animal Health is investing $895 million in its Kansas facility. Novo Nordisk anticipates Wegovy sales recovery ...

Branded drug manufacturers, including Eli Lilly and Company (Eli Lilly), have been pursuing various legal actions against compounding pharmacies ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

WBZ-TV's Dr. Mallika Marshall reports that drug maker Eli Lilly put its own weight loss drug Zepbound against the popular drug Wegovy, and Zepbound outperformed, causing 6% more weight loss than its ...

April 23 (UPI) --Eli Lilly Wednesday ... versions of Lilly drugs to get around Food and Drug Administration rules. The suits filed Wednesday are the latest in an ongoing battle Lilly is waging ...

Attorney James Gourley details the many legal issues surrounding the GLP-1 drug market and offers advice to companies on how ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

The legal battle unfolds To understand what’s happening ... existed and that the FDA had improperly relied on data from Eli Lilly (maker of Mounjaro and Zepbound) to make its decision.